In February 2019, Kate Mahady, Director of FB Rice R&D Tax Consulting, appeared on Your Money to discuss the proposed changes to the R&D tax incentive program, and the potential effect on the Australian biotechnology sector.

Joining Kate on the Your Money panel was Matt McNamara (CEO of BioScience Managers), Richard Hopkins (Managing Director of Zelda Therapeutics) and David Blake (Co-Founder of Bioshares).

The segment is available to watch on demand below.


For further information, contact Kate Mahady or click through below to our R&D Tax & Incentives webpage.